Blood-based biomarkers of tumor sensitivity to PD-1 antagonists
US-11326211-B2 · May 10, 2022 · US
This page is not indexed by search engines while we improve data quality.
Ayers Mark patents
Ayers Mark is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ayers Mark |
| Total patents | 6 |
| First publication | Feb 26, 2015 |
| Latest publication | May 10, 2022 |
Notable patents
Publications ranked by popularity score, then publication date.
Blood-based biomarkers of tumor sensitivity to pd-1 antagonists
US-2018148790-A1 · May 31, 2018 · US
Gene signature biomarkers of tumor response to pd-1 antagonists
US-2016312295-A1 · Oct 27, 2016 · US
Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
US-2016312297-A1 · Oct 27, 2016 · US
Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonists
US-2016304969-A1 · Oct 20, 2016 · US
Igf1 biomarker for igf1r inhibitor therapy
US-2015056191-A1 · Feb 26, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merck Sharp & Dohme | 6 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12Q1/6886 | 6 |
| C12Q2600/106 | 6 |
| C12Q2600/158 | 6 |
| C07K16/2818 | 3 |
| A61K39/39558 | 3 |